Neuroview Technology
Englewood, US · Founded 2016 · Delaware corporation
Neuroview Technology develops a small implantable subcutaneous device for long-term EEG brain monitoring, transmitting neurological data to the cloud via a patient's smartphone for review by clinicians. The platform applies AI/ML data analytics to EEG data to improve diagnosis and management of epilepsy and other neurologic disorders.
Founders & leadership
LR
Louis RauchenbergerNamed on SEC filing
RK
Ruben Kuzniecky, M.D.Named on SEC filing
SP
Steve Pacia, M.D.Named on SEC filing
MG
Mark GoldstoneNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$554.5K disclosed across 2 rounds · 2018–2023
▶$250KraisedDec 2023 · 1 investors · OtherRule 506(b)
▶$250KraisedDec 2023 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James KarwelExecutive Officer, Director
- Louis RauchenbergerDirector
- Werner Doyle, M.D.Director
- Ruben Kuzniecky, M.D.Executive Officer, Director
- Steve Pacia, M.D.Director
- Offering amount
- $4.8M
- Amount sold
- $250K
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$304.5KraisedJun 2018 · 6 investors · OtherRule 506(b)
▶$304.5KraisedJun 2018 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Louis RauchenbergerDirector
- Ruben Kuzniecky, M.D.Executive Officer, Director
- Steve Pacia, M.D.Director
- Mark GoldstoneDirector
- Offering amount
- $5M
- Amount sold
- $304.5K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Neuroelectrics18 shared keywordsNeuroelectrics develops the Starstim platform, combining EEG monitoring headpieces, cloud-based delivery, and personalized protocols to deliver non-invasive Transcranial Electrical Stimulation (tES) neuromodulation therapy for brain disorders such as depression and epilepsy. It serves patients whose conditions are not controlled by drugs or surgery, as well as neuroscience researchers who use its tools for brain research.
NeuroSky17 shared keywordsNeuroSky develops single-lead EEG sensors and brainwave headsets that deliver real-time brain-computer interface (BCI) data. It serves consumers as well as OEMs and developers building applications across health, education, and entertainment.
NeuroPace12 shared keywordsNeuroPace is a commercial-stage medical device company that develops the RNS System, a brain-responsive neurostimulation platform delivering real-time treatment at the seizure source for patients with drug-resistant epilepsy and other brain disorders.
Rf Surgical11 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Neuroview Technology for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Neuroview Technology do?
- Neuroview Technology develops a small implantable subcutaneous device for long-term EEG brain monitoring, transmitting neurological data to the cloud via a patient's smartphone for review by clinicians. The platform applies AI/ML data analytics to EEG data to improve diagnosis and management of epilepsy and other neurologic disorders.
- How much funding has Neuroview Technology raised?
- Neuroview Technology has disclosed $554.5K raised across 2 rounds.
- Where is Neuroview Technology headquartered?
- Neuroview Technology is headquartered in Englewood, US.